These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6208666)

  • 21. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.
    Whitnack E; Beachey EH
    J Exp Med; 1985 Dec; 162(6):1983-97. PubMed ID: 3906018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Creation and analysis of a bank of chromosomal genes of Streptococcus group A].
    Nesterchuk LB; Gupalova TV; Kolesnichenko TG; Suvorov AN; Golubkov VI
    Mol Gen Mikrobiol Virusol; 1989 Feb; (2):42-6. PubMed ID: 2661999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci.
    Jones KF; Fischetti VA
    J Exp Med; 1988 Mar; 167(3):1114-23. PubMed ID: 2450950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.
    Areschoug T; Carlsson F; Stålhammar-Carlemalm M; Lindahl G
    Vaccine; 2004 Dec; 22 Suppl 1():S9-S14. PubMed ID: 15576204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [OF- and anti-OF test systems in microbiological and epidemiologic practice].
    Beliakova IV; Totolian AA
    Vestn Akad Med Nauk SSSR; 1989; (11):54-9. PubMed ID: 2483011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary prevention of rheumatism: the status and outlook (vaccine)].
    Rotta Y
    Ter Arkh; 1985; 57(11):97-100. PubMed ID: 3909476
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biological and immunological properties of native streptococcal M protein isolated by use of endo-N-acetylmuramidase, especially the production of opsonic antibody].
    Usami H
    Nihon Saikingaku Zasshi; 1985 Mar; 40(2):477-99. PubMed ID: 3897617
    [No Abstract]   [Full Text] [Related]  

  • 30. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.
    Carlsson F; Berggård K; Stålhammar-Carlemalm M; Lindahl G
    J Exp Med; 2003 Oct; 198(7):1057-68. PubMed ID: 14517274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Streptococcal immunoglobulin Fc reception and its participation in poststreptococcal complications].
    Burova LA; Totolian AA; Christensen P; Schalén C
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):12-20. PubMed ID: 6395582
    [No Abstract]   [Full Text] [Related]  

  • 32. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin.
    Vashishtha A; Fischetti VA
    J Immunol; 1993 May; 150(10):4693-701. PubMed ID: 8482854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future streptococcal M. vaccine against rheumatic fever.
    Imran M; Jan A
    J Pak Med Assoc; 1988 Jul; 38(7):176-7. PubMed ID: 3149682
    [No Abstract]   [Full Text] [Related]  

  • 34. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics.
    Hoe NP; Kordari P; Cole R; Liu M; Palzkill T; Huang W; McLellan D; Adams GJ; Hu M; Vuopio-Varkila J; Cate TR; Pichichero ME; Edwards KM; Eskola J; Low DE; Musser JM
    J Infect Dis; 2000 Nov; 182(5):1425-36. PubMed ID: 11015234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex surveillance of Streptococcus pyogenes V. Protective features complex surveillance of streptococcus of cell-mediated immunity against group a streptococci.
    Kahlich R; Procházka O; Svec M
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):396-404. PubMed ID: 6761393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clindamycin and its action on the susceptibility of pathogenic bacteria to phagocytosis.
    Gemmell CG
    Scand J Infect Dis Suppl; 1984; 43():17-23. PubMed ID: 6398907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Academy of Dermatology 1998 Awards for Young Investigators in Dermatology. Detection of streptococcal antigens in psoriasis.
    Talanin NY
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):270-1. PubMed ID: 9704841
    [No Abstract]   [Full Text] [Related]  

  • 38. Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies.
    Dale JB; Beachey EH
    Infect Immun; 1984 Oct; 46(1):267-9. PubMed ID: 6207110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation.
    Shannon O; Hertzén E; Norrby-Teglund A; Mörgelin M; Sjöbring U; Björck L
    Mol Microbiol; 2007 Sep; 65(5):1147-57. PubMed ID: 17662041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody to human renal glomeruli cross-reacts with streptococcal M protein.
    Goroncy-Bermes P; Dale JB; Beachey EH; Opferkuch W
    Infect Immun; 1987 Oct; 55(10):2416-9. PubMed ID: 2443450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.